跳至主要内容
临床试验/NCT00751452
NCT00751452Unknown不适用

Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
Citrullinemia (weekly)

研究概览

简要总结

determine the interest of the dosage of citrullinemia to monitor the bowel damage after allogeneic bone marrow transplantation in children.

详细描述

30 children included. Dosage of citrullinemia on day -7, day 0 and every week up to 100 days after BMT. Histological examination and extensive infectious screening in case of persistent digestive symptoms (more than 3 days).

Two groups of patients regarding on digestive involvement. Comparison of the values of citrullinemia between these two groups.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 0 to 18 years
  • allogeneic bone marrow transplantation for malignant or benign disease
  • affiliation to French sécurité sociale
  • parent's consent

排除标准

  • severe gastro-intestinal involvement before transplant
  • previous digestive surgery

结局指标

主要结局

Citrullinemia (weekly)

时间窗: weekly

次要结局

  • Gastro-intestinal complications in children following allogeneic bone marrow transplantation(following allogenic bone marrow transplantation)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other

研究点 (1)

Loading locations...

相似试验